Detalles de la búsqueda
1.
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 24-week efficacy and safety results from a randomized, double-blinded trial.
Br J Dermatol
; 184(6): 1047-1058, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32880909
2.
Comorbidities of alopecia areata: a population-based cohort study.
Clin Exp Dermatol
; 46(4): 651-656, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33175413
3.
Dual Coaxial Longitudinal Polarization Vortex Structures.
Phys Rev Lett
; 124(10): 103901, 2020 Mar 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32216411
4.
A head-to-head comparison of ixekizumab vs. guselkumab in patients with moderate-to-severe plaque psoriasis: 12-week efficacy, safety and speed of response from a randomized, double-blinded trial.
Br J Dermatol
; 182(6): 1348-1358, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31887225
5.
Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate-to-severe genital psoriasis.
J Eur Acad Dermatol Venereol
; 34(6): 1257-1262, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-31919919
6.
Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis.
J Eur Acad Dermatol Venereol
; 34(1): 39-46, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31465593
7.
Characteristics and prevalence of plaque psoriasis in patients with palmoplantar pustulosis.
Br J Dermatol
; 181(5): 976-982, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30815849
8.
Minimal clinically important difference (MCID) for work productivity and activity impairment (WPAI) questionnaire in psoriasis patients.
J Eur Acad Dermatol Venereol
; 33(2): 318-324, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-29846976
9.
Efficacy and safety of ixekizumab in a randomized, double-blinded, placebo-controlled phase IIIb study of patients with moderate-to-severe genital psoriasis.
Br J Dermatol
; 179(4): 844-852, 2018 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-29747232
10.
Impact of ixekizumab on facial psoriasis and related quality of life measures in moderate-to-severe psoriasis patients: 12-week results from two phase III trials.
J Eur Acad Dermatol Venereol
; 32(1): 68-72, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28881462
11.
Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States.
Osteoporos Int
; 28(3): 799-809, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28028555
12.
Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population.
Osteoporos Int
; 28(8): 2485-2494, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28536737
13.
Rapid improvements in health-related quality of life and itch with ixekizumab treatment in randomized phase 3 trials: results from UNCOVER-2 and UNCOVER-3.
J Eur Acad Dermatol Venereol
; 31(9): 1483-1490, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-28294430
14.
Ixekizumab provides persistent improvements in health-related quality of life and the sexual impact associated with moderate-to-severe genital psoriasis in adult patients during a 52-week, randomised, placebo-controlled, phase 3 clinical trial.
J Eur Acad Dermatol Venereol
; 36(4): e277-e279, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-34812561
15.
Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis.
J Eur Acad Dermatol Venereol
; 31(6): 1004-1013, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28190255
16.
Impact of ixekizumab treatment on skin-related personal relationship difficulties in moderate-to-severe psoriasis patients: 12-week results from two Phase 3 trials.
J Eur Acad Dermatol Venereol
; 31(11): 1867-1875, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28573743
17.
Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database.
Osteoporos Int
; 27(9): 2855-2865, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27172935
18.
FRAX and the effect of teriparatide on vertebral and non-vertebral fracture.
Osteoporos Int
; 26(11): 2677-84, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26092063
19.
Corrigendum: Systematic review on rapidity of onset of action for interleukin-17 and interleukin-23 inhibitors for psoriasis.
J Eur Acad Dermatol Venereol
; 34(9): 2156, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33448477
20.
Efficacious psoriasis treatment improves patients' work productivity.
J Eur Acad Dermatol Venereol
; 34(10): e593-e596, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32277526